Poster Presentations / Osteoarthritis and Cartilage 18, Supplement 2 (2010) S45-S256 S119 bers to exert their cytoprotective effects which may be mediated through a mechanism involving Kir 6.1-containing mitochondrial potassium channels, which we have also shown to exist in this cell line. The observation that these cells express both CRFR1 and CRFR2 is novel in that CRFR1 are largely confined to the central nervous system in humans, but would explain the greater potency of Ucn I in chondroprotection as this peptide binds to both CRFR1 and CRFR2 whilst Ucn II and Ucn III are selective CRFR2 ligands. The demonstration that Ucn treatment results in p42/44 MAPK activation also suggest the involvement of other cytoprotective mechanisms (e.g. cAMP and PKA modulated responses) in Ucn mediated chondroprotection. Purpose: NF-kappaB transcription factor regulates several cell signaling pathways, such as differentiation and inflammation, which are both altered in osteoarthritis. IKKalpha and IKKbeta are kinases involved in the activation of the NF-kappaB transcription factor. The aim of the present study was to determine the effects of glucosamine, which is administered in the treatment of osteoarthritis, and of its 2-(N-Acetyl)-L-phenylalanylamido-2-deoxy-beta-D-glucose derivative (glucosamine-derivative) on IKK kinases and, consequently, on NF-kappaB activation in human chondrocytes. Methods: The human chondrosarcoma cell line HTB-94 and human primary chondrocytes were stimulated with TNFalpha after pre-treatment with glucosamine or glucosamine-derivative. Gene mRNA expression level was evaluated by Real Time-PCR. IkappaBalpha phosphorylation and p65 nuclear translocation were analyzed by Western blotting, IKKalpha nuclear re-localization was investigated by immunocytochemistry and by Western blotting. IKK kinase activity was studied by in vitro kinase assay, using IKK complex immunoprecipitated by cells or using recombinant IKkalpha and IKKbeta. Results: After TNFalpha stimulation, the mRNA expression level of some of the genes under NF-kappaB control, such as IL-6 and IL-8, increased, while treatment with glucosamine and glucosamine-derivative reverted the effect. We investigated the possibility that flucosamine and its derivative inhibit IKK kinase activity and found that glucosamine-derivative inhibits the IKKalpha kinase activity, whereas glucosamine does not. Interestingly, both molecules inhibit IKKalpha nuclear translocation.
Purpose: Chondrocytes become hypertrophic, which leads to calcification of cartilage matrix. This is a pathological event in the early phase of osteoarthritis (OA). We are interested in three subpopulations: pre-hypertrophic chondrocytes, hypertrophic chondrocytes and mature hypertrophic chondrocytes, which are undergoing apoptosis. These three subpopulations of hypertrophic chondrocytes play different role in pathogenesis of OA. The aim of our work was to develop and validate an ex vivo model, which includes the different subpopulations of chondrocytes, and in which hypertrophic chondrocytes could be induced by adding appropriate factors. This model was supposed to be used for examination of cartilage changes related to morphological changes. Thus, aiding the understanding of the role of hypertrophy chondrocytes in OA pathogenesis. Methods: Full depth cartilage explants (from superficial to calcified cartilage) were isolated from bovine femoral condyle and cultured for 21 days with different stimulators: 1) TNF-α [20ng/ml] + Oncostatin M [10ng/ml], 2) IGF-1 [100ng/ml], 3) bFGF [50ng/ml], and 4) BMP-2[100ng/ml]. Supernatants were collected every two or three days. Safranin O/Fast Green (SaFO) and Tuludine Blue (TuB) staining were used to distinguish the morphology of the explants. Collagen type II turnover was measure by PIINP (formation) and CIIMB (degradation) assay. As markers of hypertrophy chondrocytes, expression of Indian hedgehog, type X collagen, ALP and MMP-13 were evaluated using reverse transcription followed by real-time polymerase chain reaction (PCR) at day 14. Results: Alamarblue data showed that all explants were alive throughout the 21 days. Both IGF-1 and bFGF groups had enlarged cells at day 7 and 14 (TuB and SaFO stainings). CIIMB and PIINP assay results suggested that both IGF-1 and bFGF had significant (p<0.05) collagen type II degradation and formation at day 7, but not day 14 and 21. BMP-2 increased significantly expression of Ihh, COL X, ALP and MMP-13 at day 14 (p<0.0001) compared with W/O. bFGF increased expression of Ihh and MMP-13 but not significantly, and the expression of COL X and ALP of bFGF stimulated group were lower than W/O. The increased expression of hypertrophy chondrocytes markers confirmed that BMP-2 could induce chondrocytes hypertrophic in FDC model.
Conclusions:
We have developed an explants culture models that include all the different layers of the articular cartilage and were able to induce hypertrophy by stimulating with BMP-2. We could detect the gene expression of markers at different subpopulations of chondrocytes in the ex vivo culture model. We speculate that this model could be used as an important ex vivo model for simulating cartilage degenerative diseases and thereby for investigating the effect of different drug candidates.
GLUCOCORTICOIDS ATTENUATE BONE TURNOVER, BUT DO NOT APPEAR TO AFFECT CHONDROCYTESIN VITRO
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Purpose: Glucocorticoids are known to attenuate bone formation in vivo leading to decreased bone volume and increased risk of fractures, whereas effects on the joint tissue are not known. This study aimed at characterizing the effect of glucocorticoids on osteoclasts and osteoblasts, as well as the closely related chondrocytes. Methods: We used CD14+ monocytes cultured in the presence of M-CSF and RANKL to investigate the effect of glucocorticoids on different osteoclastic parameters. We measured TRACP activity and Calcium release as indices of osteoclast number and activity. 2T3 preosteoblastic cells we used to characterize the effects of glucocorticoids on bone formation, either in the presence or absence of BMP-2. Alizarin Red was used to measure nodule formation, ALP activity as an indicator of osteoblastogenesis. Bovine full depth cartilage explants were cultured with or without TNF-a, OSM and IGF-1 to characterize the effects of glucocorticoids on cartilage turnover. Collagen type II degradation was measured by CIIMB, and aggrecan degradation by 373-G1. Safranin O staining was used to investigate proteoglycan content in sections of the cultured explants. In all assays Alamar Blue was used as an indicator of viability. Results: DEX and PRED dose-dependently inhibited osteoclastogenesis by promoting cell death. For mature osteoclasts, low doses of GLUC induced bone resorption short term, whereas high doses and continued exposure led to osteoclast death. In osteoblasts glucocorticoids induced cell death in the non-stimulated cells. For BMP-2 stimulated cells; we found that GLUCs augmented nodule formation, while still reducing cell viability. In cartilage we found that GLUCs were unable to alter cartilage turnover, although at high concentrations a minor reduction in safranin O staining intensity was observed. Conclusions: In summary, using highly robust models of bone and cartilage turnover, we have shown that the effects of glucocorticoids on bone depend very much in the cell targeted, i.e. activated osteoblasts are further activated by GLUC, whereas non-activated cells undergo cell death. In cartilage no apparent effects were observed, indicating that cartilage may not possess glucocorticoid receptors, or that these are not active. We believe that these model systems are highly relevant for the continued development of glucocorticoid analogues without the detrimental effect on bone
